934810-99-8

Upstream product

• 753-90-2 trifluoroethylamine 
• 98-58-8 4-bromobenzenesulfonyl chloride 

Downstream Products

• 1572928-34-7 4-(2-(1-propyn-1-yl)-1-piperazinyl)-N-(2,2,2-trifluoroethyl)benzenesulfonamide 
• 1572928-35-8 tert-butyl (5-((3-(1-propyn-1-yl)-4-(4-((2,2,2-trifluoroethyl)sulfamoyl)phenyl)-1-piperazinyl)sulfonyl)-2-pyridinyl)carbamate 
• 1572927-64-0 4-((2S)-4-((6-amino-3-pyridinyl)sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)-N-(2,2,2-trifluoroethyl)benzenesulfonamide 
• 1572927-65-1 4-((2R)-4-((6-amino-3-pyridinyl)sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)-N-(2,2,2-trifluoroethyl)benzenesulfonamide 
• 1572928-33-6 benzyl 3-(1-propyn-1-yl)-4-(4-((2,2,2-trifluoroethyl)sulfamoyl)phenyl)-1-piperazinecarboxylate 

Relevant academic research and scientific papers

TRICYCLIC ALKYNES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN

The present invention relates to tricyclic alkyne compounds of formula I that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where gluco

ARYL SULFONAMIDES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR

In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception; treating or preventing fibroids; trea